Masimo (NSDQ:MASI) announced today that it received FDA clearance for its PVi for fluid responsiveness indication in ventilated adult patients.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,